Genome-Wide Analysis of Survival in Early-Stage Non–Small-Cell Lung Cancer
View/ Open
zlj2660.pdf (196.8Kb)
Access Status
Full text of the requested work is not available in DASH at this time ("restricted access"). For more information on restricted deposits, see our FAQ.Author
Skaug, Vidar
Zienolddiny, Shanbeh
Haugen, Aage
Wu, Michael C.
Published Version
https://doi.org/10.1200/jco.2008.18.7906Metadata
Show full item recordCitation
Huang, Yen-Tsung, Rebecca Suk Heist, Lucian Chirieac, Xihong Lin, Vidar Skaug, Shanbeh Zienolddiny, Aage Haugen et al. "Genome-Wide Analysis of Survival in Early-Stage Non–Small-Cell Lung Cancer." Journal of Clinical Oncology 27, no. 16 (2009): 2660-2667. DOI: 10.1200/jco.2008.18.7906Abstract
PurposeLung cancer, of which 85% is non–small-cell (NSCLC), is the leading cause of cancer-related death in the United States. We used genome-wide analysis of tumor tissue to investigate whether single nucleotide polymorphisms (SNPs) in tumors are prognostic factors in early-stage NSCLC.
Patients and Methods
One hundred early-stage NSCLC patients from Massachusetts General Hospital (MGH) were used as a discovery set and 89 NSCLC patients collected by the National Institute of Occupational Health, Norway, were used as a validation set. DNA was extracted from flash-frozen lung tissue with at least 70% tumor cellularity. Genome-wide genotyping was done using the high-density SNP chip. Copy numbers were inferred using median smoothing after intensity normalization. Cox models were used to screen and validate significant SNPs associated with the overall survival.
Results
Copy number gains in chromosomes 3q, 5p, and 8q were observed in both MGH and Norwegian cohorts. The top 50 SNPs associated with overall survival in the MGH cohort (P ≤ 2.5 × 10−4) were selected and examined using the Norwegian cohort. Five of the top 50 SNPs were validated in the Norwegian cohort with false discovery rate lower than 0.05 (P < .016) and all five were located in known genes: STK39, PCDH7, A2BP1, and EYA2. The numbers of risk alleles of the five SNPs showed a cumulative effect on overall survival (Ptrend = 3.80 × 10−12 and 2.48 × 10−7 for MGH and Norwegian cohorts, respectively).
Conclusion
Five SNPs were identified that may be prognostic of overall survival in early-stage NSCLC.
Other Sources
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2690391/Citable link to this page
https://nrs.harvard.edu/URN-3:HUL.INSTREPOS:37369348
Collections
- HMS Scholarly Articles [17922]
Contact administrator regarding this item (to report mistakes or request changes)